Literature DB >> 12098070

Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.

C G Brunstein1, B A Hirsch, D Hammerschmidt, R C McGlennen, P L Nguyen, C M Verfaillie.   

Abstract

The development of leukemia in donor cells after allogeneic hematopoietic stem cell transplant is an extremely rare event. We report here the case of a patient who developed myelodysplastic syndrome/acute myeloid leukemia, in cells of donor origin 3.5 years after related donor HSCT for refractory chronic lymphocytic leukemia and therapy-induced myelodysplastic syndrome. The origin of the leukemia was determined by analysis of minisatillite polymorphism tested on CD34(+) cells.

Entities:  

Mesh：

Year:  2002        PMID： 12098070     DOI： 10.1038/sj.bmt.1703577

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  11 in total

1.  First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation.

Authors:  Christopher J Fraser; Betsy A Hirsch; Vanessa Dayton; Michael H Creer; Joseph P Neglia; John E Wagner; K Scott Baker
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  Donor-derived second hematologic malignancies after cord blood transplantation.

Authors:  Karen K Ballen; Corey Cutler; Beow Y Yeap; Steven L McAfee; Bimalangshu R Dey; Eyal C Attar; Yi-Bin Chen; Richard L Haspel; Deborah Liney; John Koreth; Vincent Ho; Edwin P Alyea; Robert J Soiffer; Thomas R Spitzer; Joseph H Antin
Journal:  Biol Blood Marrow Transplant       Date:  2010-02-21       Impact factor: 5.742

3.  Development of lymphoma from the donor of haploidentical stem cell transplantation: A case report.

Authors:  Linna Xie; Fang Zhou
Journal:  Mol Clin Oncol       Date:  2017-09-19

4.  Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making.

Authors:  Yusuke Shono; Mizuha Kosugi-Kanaya; Souichi Shiratori; Junichi Sugita; Katsuya Fujimoto; Takeshi Kondo; Mitsufumi Nishio; Junji Tanaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2011-04-09       Impact factor: 2.490

5.  Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.

Authors:  Nirali N Shah; Ulrike Bacher; Terry Fry; Katherine R Calvo; Maryalice Stetler-Stevenson; Diane C Arthur; Roger Kurlander; Kristin Baird; Barbara Wise; Sergio Giralt; Michael Bishop; Nancy M Hardy; Alan S Wayne
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

Review 6.  Risks and mechanisms of oncological disease following stem cell transplantation.

Authors:  Sergey V Anisimov; Asuka Morizane; Ana S Correia
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

Review 7.  Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review.

Authors:  Makoto Murata; Yuichi Ishikawa; Haruhiko Ohashi; Seitaro Terakura; Kazutaka Ozeki; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2008-05-10       Impact factor: 2.490

8.  The Important Role of FLT3-L in Ex Vivo Expansion of Hematopoietic Stem Cells following Co-Culture with Mesenchymal Stem Cells.

Authors:  Farhad Oubari; Naser Amirizade; Hemn Mohammadpour; Mozhdeh Nakhlestani; Mahin Nikougoftar Zarif
Journal:  Cell J       Date:  2015-07-11       Impact factor: 2.479

9.  RSV-Related Thrombocytopenia Associated with Transient Cytogenetic Abnormalities in a Recipient of Umbilical Cord Blood Transplantation.

Authors:  Sabita D Pokhrel; Diane L Persons; Omar S Aljitawi
Journal:  Case Rep Hematol       Date:  2016-02-02

10.  Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case?

Authors:  Mirko Farina; Simona Bernardi; Lisa Gandolfi; Camilla Zanaglio; Enrico Morello; Alessandro Turra; Tatiana Zollner; Doriana Gramegna; Benedetta Rambaldi; Federica Cattina; Nicola Polverelli; Michele Malagola; Domenico Russo
Journal:  Front Oncol       Date:  2020-10-14       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.